会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • 2-carbamimidoyl-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids
    • 2-甲脒基-6-取代-1-碳代二烯-2-烯-3-羧酸
    • US4997936A
    • 1991-03-05
    • US898887
    • 1986-08-21
    • Burton G. ChristensenDavid B. R. JohnstonSusan M. Schmitt
    • Burton G. ChristensenDavid B. R. JohnstonSusan M. Schmitt
    • C07C205/42C07C205/43C07D205/08C07D477/04C07D477/20C07D477/26C07D498/04C07D519/00C07F7/10
    • C07F7/10C07C205/42C07C205/43C07D205/08C07D477/04C07D477/20C07D477/26
    • Disclosed are 2- and 6-substituted-1-carbadethiapen-2-em-3-carboxylic acids having the structure: ##STR1## wherein R.sup.6, and R.sup.7 are, inter alia, independently selected from the group consisting of hydrogen, alkyl, alkenyl, aryl and aralkyl; A is a direct, single bond connecting the indicated S and C atoms, or A is a cyclic or acyclic connecting group selected, inter alia, from alkyl, cyclalkyl, aryl, heteroaryl, heteroalkyl; R.sup.1 and R.sup.2 inter alia, independently selected from hydrogen, alkyl, aryl; additionally, said carbamimidoyl is characterized by cyclic structures achieved by the joinder of the two nitrogen atoms via their substituents and by their joinder to connecting group A; additionally, "carbamimidiums" are disclosed by quarternization of one of the nitrogen atoms of said carbammidoyl. Such compounds as well as their pharmaceutically acceptable salt, ester and amide derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds; pharamaceutical compositions comprising such compounds; and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.
    • 公开了具有以下结构的2-和6-取代-1-碳代二脱氧-2-烯-3-羧酸:其中R 6和R 7尤其独立地选自氢,烷基,烯基 ,芳基和芳烷基; A是连接所指示的S和C原子的直接的单键,或A是选自烷基,环烷基,芳基,杂芳基,杂烷基的环状或无环连接基团。 R1和R2特别地独立地选自氢,烷基,芳基; 另外,所述的氨基甲脒基的特征在于通过两个氮原子通过它们的取代基并通过它们与连接基团A的连接而实现的环状结构; 此外,“氨基甲酰胺”是通过所述碳酰胺基的氮原子之一的季化来公开的。 这些化合物及其药学上可接受的盐,酯和酰胺衍生物可用作抗生素。 还公开了制备这些化合物的方法; 包含这些化合物的药用组合物; 和治疗方法,包括当指出抗生素效应时施用这些化合物和组合物。